Inclusion of HPV testing in routine cervical cancer screening for women above 29 years in Germany: Results for 8466 patients

Petry, Ulrich; Menton, Susanne; Menton, Michael; van Loenen-Frosch, F.; De Carvalho Gomes, H.; Holz, Barbara; Schopp, Betti; Garbrecht-Buettner, S.; Davies, Peter; Boehmer, Gerd; van den Akker, Erica; Iftner, Thomas

doi:10.1038/sj.bjc.6600918

In a prospective cohort study 8466 women attending routine cervical cancer screening were recruited. Colposcopy was performed on women with any degree of atypia on cytology and/or a positive high-risk human papillomavirus (HPV)-DNA test (HC2; Hybrid Capture 2

Additional Metadata
Keywords	Cervical cancer screening, Cytology performance, HPV test performance
Persistent URL	doi.org/10.1038/sj.bjc.6600918, hdl.handle.net/1765/72449
Journal	British Journal of Cancer
Organisation	Erasmus MC: University Medical Center Rotterdam
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Petry, U., Menton, S., Menton, M., van Loenen-Frosch, F., De Carvalho Gomes, H., Holz, B., … Iftner, T. (2003). Inclusion of HPV testing in routine cervical cancer screening for women above 29 years in Germany: Results for 8466 patients. British Journal of Cancer, 88(10), 1570–1577. doi:10.1038/sj.bjc.6600918

Inclusion of HPV testing in routine cervical cancer screening for women above 29 years in Germany: Results for 8466 patients

Publication

Publication

About

Inclusion of HPV testing in routine cervical cancer screening for women above 29 years in Germany: Results for 8466 patients

Publication

Publication

Workflow

Workflow

Add Content